New methods for the discovery and synthesis of PDE7 inhibitors as new drugs for neurological and inflammatory disorders

Author： Safavi Maliheh Baeeri Maryam Abdollahi Mohammad

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.8, Iss.6, 2013-10, pp. : 733-751

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PDE7 inhibitors as new drugs for neurological and inflammatory disorders

By Gil Carmen Campillo Nuria E Perez Daniel I Martinez Ana

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 10, 2008-10 ,pp. : 1127-1139

Informa Healthcare

Access to resources Recommend Favorite

QSAR methods for the discovery of new inflammatory bowel disease drugs

By García-Domenech Ramón

Expert Opinion on Drug Discovery, Vol. 8, Iss. 8, 2013-11 ,pp. : 933-949

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in PDE4 Inhibitors as Immunoregulators and Anti- Inflammatory Drugs

Current Pharmaceutical Design, Vol. 8, Iss. 14, 2002-06 ,pp. : 1255-1296

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?

By Teixeira M.M. Gristwood R.W. Cooper N. Hellewell P.G.

Trends in Pharmacological Sciences, Vol. 18, Iss. 5, 1997-05 ,pp. : 164-170

Elsevier

Access to resources Recommend Favorite

Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery

Current Pharmaceutical Design, Vol. 22, Iss. 21, 2016-06 ,pp. : 3073-3081

Bentham Science Publishers

Access to resources Recommend Favorite